Sign inGet started

Gruber James R.

Insider CIK 1923165 · ETON Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ETON Eton Pharmaceuticals, Inc. F Tax w/h2026-01-142026-01-142,293$15.47 $35.5K213,420SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2026-01-122026-01-1440,655— $0254,075SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2026-01-122026-01-1425,856— $0279,931SEC↗
ETON Eton Pharmaceuticals, Inc. F Tax w/h2025-12-122025-12-124,542$16.99 $77.2K215,713SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2025-12-112025-12-125,502— $0210,255SEC↗
ETON Eton Pharmaceuticals, Inc. S Sale2025-08-202025-08-202,631$16.02 $42.1K204,753SEC↗
ETON Eton Pharmaceuticals, Inc. S Sale2025-08-192025-08-2039,082$16.16 $631.6K205,299SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2025-01-032025-01-0625,876— $025,876SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2025-01-032025-01-0638,621— $038,621SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2024-02-132024-02-15144,677— $0374,763SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2023-03-032023-03-03100,086— $0200,086SEC↗
ETON Eton Pharmaceuticals, Inc. A Award deriv2022-07-122022-07-1840,000— $040,000SEC↗